Boni E. Elewski

Boni Elewski practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Boni Elewski's NPI, 1437192317, was assigned on June 14, 2006. Boni Elewski graduated from Ohio State University College of Medicine in 1978. Boni Elewski holds Alabama license 22723.

Boni Elewski's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Boni Elewski's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Boni Elewski is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Boni Elewski practices. Vendor and product names are available with a free account.

Dermatology is Boni Elewski's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Boni Elewski is licensed in Alabama.

CMS data shows 1,193 Medicare services from Boni Elewski across 12 procedure codes in 2024, for 247 Medicare patients. Medicare paid $32,151 for them.

CMS counts 247 Medicare patients who saw Boni Elewski in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Boni Elewski's median patient age at 70, with 64% women.

In 2024, Boni Elewski wrote 699 Medicare Part D claims for 171 patients. 67% of them were for generic drugs. CMS names the drug for 570 of them, across 20 drugs with 11 or more claims each, at $1,142,247 in total drug cost. In 2023, CMS named 548 claims across 18 drugs.

Boni Elewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Boni Elewski as offering telehealth. CMS counts 294 procedures of removal of skin lesions by Boni Elewski, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 150 papers to Boni Elewski, published from 2007 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Psoriasis, Antifungal Agents and Onychomycosis. Boni Elewski has published most often in J Drugs Dermatol. Boni Elewski's most frequent co-authors are Mark Gabriel Lebwohl, Craig A. Elmets, MD and Theresa Nicole Canavan.

Dmand AI links Boni Elewski to 12 clinical trials, 3 of them phase 3 studies. Conditions studied include Psoriasis, Skin Diseases, Papulosquamous and Eczema. Eli Lilly and Company sponsors the most, 7. Open Payments lists research payments to Boni Elewski that name 5 trials.

CMS Open Payments shows 301 general payments to Boni Elewski from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Novartis Pharmaceuticals Corporation paid the most, $61,663. It also lists 35 research payments totaling $575,905 from 2016 to 2023, naming 5 clinical trials.

Boni Elewski graduated from Ohio State University College of Medicine in 1978.